Novel and Underutilized Strategies to Improve Adherence and Reduce Relapse Risk in Schizophrenia

(New York, NY) – June 16, 2014 – AiCure, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, was invited to speak today at the American Society of Clinical Psychopharmacology (ASCP) 54th Annual Meeting, in Hollywood, FL, June 16 – 19, 2014. Adam Hanina, CEO, presented and participated in the panel discussion “Novel and Underutilized Strategies to Improve Adherence and Reduce Relapse Risk in Schizophrenia” alongside John M. Kane, MD, Vice President for Behavioral Health Services of the North Shore – Long Island Jewish Health System and Chairman of Psychiatry at The Zucker Hillside Hospital and Dror Ben-Zeev, PhD, assistant professor of psychiatry at Dartmouth.